- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NIDA
Recent news which mentions NIDA
Fed Health Official: Cannabis Industry Borrowing Marketing Tactics From Tobacco, Alcohol Industries
October 02, 2024
Tickers
NEWS
From Benzinga
Federal Drug Official: Treating Drug Addiction With Incarceration Is Ineffective And 'Dangerous,' Calls For Overhaul
July 16, 2024
From Benzinga
Top Federal Drug Official Praises Psychedelics' Potential, Psilocybin And Ketamine On City Health Plans And More
May 29, 2024
Tickers
NEWS
From Benzinga
The Kids Are Alright: Government Study Finds Teen Cannabis Use Holds Steady Despite Increased State Legalization
December 13, 2023
From Benzinga
Canada Vs. US: Surveys Reveal How People Use Psychedelics, Relationships With Healthcare Providers
August 23, 2023
From Benzinga
Cannabis, Psychedelics Use And Binge Drinking At All-Time High Among Adults, Teens Remain Stable, Fed Study Finds
August 17, 2023
From Benzinga
Study Reveals Groundbreaking Treatment For Cannabis Use Disorder With A New Class Of Medication
June 09, 2023
From Benzinga
From Benzinga
Federal Psychedelics Reform Has More Lobbyists, Addiction Research Grant & Upcoming $27M VA Report
May 31, 2023
From Benzinga
NIDA Director Nora Volkow Calls Regulating Cannabis 'Crucial' As More States Legalize It
May 19, 2023
From Benzinga
NIDA Partners With The National Institute Of Mental Health To Study Psychedelics Potential
May 05, 2023
From Benzinga
NIDA Study Finds Young Men At Higher Risk Of Schizophrenia Linked With Cannabis Use Disorder
May 04, 2023
From Benzinga
Top FDA Official Says Marijuana Scheduling Review Is 'A Very High Priority,' But Who Has Final Say?
October 28, 2022
Tickers
HHS
From Benzinga
From Benzinga
NIDA Director Dr. Nora Volkow Calls For 'Urgent' Research Into Risks Of Regular Cannabis Use, Citing Effects On Brain Development
August 24, 2022
From Benzinga
From Benzinga
National Institute On Drug Abuse Seeks To Set Up Medical Marijuana Registry, Here's How It Will Function
June 16, 2022
Tickers
CBD
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.